EP2972393A4 - Biomarqueurs et procédés de prédiction de prééclampsie - Google Patents

Biomarqueurs et procédés de prédiction de prééclampsie

Info

Publication number
EP2972393A4
EP2972393A4 EP14762389.6A EP14762389A EP2972393A4 EP 2972393 A4 EP2972393 A4 EP 2972393A4 EP 14762389 A EP14762389 A EP 14762389A EP 2972393 A4 EP2972393 A4 EP 2972393A4
Authority
EP
European Patent Office
Prior art keywords
biomarkers
methods
predicting preeclampsia
preeclampsia
predicting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14762389.6A
Other languages
German (de)
English (en)
Other versions
EP2972393A2 (fr
Inventor
Durlin Edward Hickok
John Jay Boniface
Gregory Charles Critchfield
Tracey Cristine Fleischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sera Prognostics Inc
Original Assignee
Sera Prognostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sera Prognostics Inc filed Critical Sera Prognostics Inc
Priority to EP19166832.6A priority Critical patent/EP3567371A1/fr
Priority to EP23214373.5A priority patent/EP4344705A2/fr
Publication of EP2972393A2 publication Critical patent/EP2972393A2/fr
Publication of EP2972393A4 publication Critical patent/EP2972393A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
EP14762389.6A 2013-03-15 2014-03-14 Biomarqueurs et procédés de prédiction de prééclampsie Withdrawn EP2972393A4 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP19166832.6A EP3567371A1 (fr) 2013-03-15 2014-03-14 Biomarqueurs et procédés de prédiction de la prééclampsie
EP23214373.5A EP4344705A2 (fr) 2013-03-15 2014-03-14 Biomarqueurs et procédés de prédiction de la prééclampsie

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361798413P 2013-03-15 2013-03-15
PCT/US2014/028188 WO2014143977A2 (fr) 2013-03-15 2014-03-14 Biomarqueurs et procédés de prédiction de prééclampsie

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP19166832.6A Division EP3567371A1 (fr) 2013-03-15 2014-03-14 Biomarqueurs et procédés de prédiction de la prééclampsie
EP23214373.5A Division EP4344705A2 (fr) 2013-03-15 2014-03-14 Biomarqueurs et procédés de prédiction de la prééclampsie

Publications (2)

Publication Number Publication Date
EP2972393A2 EP2972393A2 (fr) 2016-01-20
EP2972393A4 true EP2972393A4 (fr) 2016-10-26

Family

ID=51538292

Family Applications (3)

Application Number Title Priority Date Filing Date
EP19166832.6A Withdrawn EP3567371A1 (fr) 2013-03-15 2014-03-14 Biomarqueurs et procédés de prédiction de la prééclampsie
EP23214373.5A Pending EP4344705A2 (fr) 2013-03-15 2014-03-14 Biomarqueurs et procédés de prédiction de la prééclampsie
EP14762389.6A Withdrawn EP2972393A4 (fr) 2013-03-15 2014-03-14 Biomarqueurs et procédés de prédiction de prééclampsie

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP19166832.6A Withdrawn EP3567371A1 (fr) 2013-03-15 2014-03-14 Biomarqueurs et procédés de prédiction de la prééclampsie
EP23214373.5A Pending EP4344705A2 (fr) 2013-03-15 2014-03-14 Biomarqueurs et procédés de prédiction de la prééclampsie

Country Status (5)

Country Link
US (5) US20140287947A1 (fr)
EP (3) EP3567371A1 (fr)
AU (3) AU2014228009A1 (fr)
CA (2) CA3210007A1 (fr)
WO (1) WO2014143977A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140287947A1 (en) * 2013-03-15 2014-09-25 Sera Prognostics, Inc. Biomarkers and methods for predicting preeclampsia
US9953417B2 (en) * 2013-10-04 2018-04-24 The University Of Manchester Biomarker method
GB201322800D0 (en) * 2013-12-20 2014-02-05 Univ Dublin Prostate cancer biomarkers
CA2977458A1 (fr) * 2015-03-16 2016-09-22 A1M Pharma Ab Biomarqueurs de la preeclampsie
BR112017027528A2 (pt) 2015-06-19 2018-09-11 Sera Prognostics, Inc. composição, painel, método para determinar a probabilidade de parto prematuro em uma fêmea grávida e método de detecção de ibp4 e shbg em uma fêmea grávida?
WO2017075027A1 (fr) * 2015-10-26 2017-05-04 Brigham Young University Biomarqueurs lipidiques sériques de la prééclampsie
US11243213B2 (en) * 2015-11-05 2022-02-08 Wayne State University Kits and methods for prediction and treatment of preeclampsia
WO2017180984A1 (fr) * 2016-04-14 2017-10-19 The Texas A&M University System Biomarqueurs épigénétiques et à micro-arn de premier trimestre pour la prééclampsie
US20180143202A1 (en) * 2016-08-05 2018-05-24 Sera Prognostics, Inc. Biomarkers for predicting preterm birth in a pregnant female exposed to progestogens
RU2019105691A (ru) * 2016-08-05 2020-09-08 Сера Прогностикс, Инк. Биомаркеры для прогнозирования преждевременных родов из-за преждевременного разрыва плодной оболочки при недоношенной беременности и идиопатических самопроизвольных родов
CN108732253A (zh) * 2017-04-14 2018-11-02 杭州量康科技有限公司 用于血清蛋白质定量测定的肽段组合物及测定方法
EP3668996A4 (fr) 2017-08-18 2021-04-21 Sera Prognostics, Inc. Protéines d'horloge de grossesse pour prévoir la date et le moment prévus de la naissance
WO2020061590A1 (fr) * 2018-09-21 2020-03-26 The Board Of Trustees Of The Leland Stanford Junior University Méthodes d'évaluation de progression gestationnelle et d'avortement prématuré destinées à une intervention clinique et applications correspondantes
WO2021021649A1 (fr) * 2019-07-26 2021-02-04 The Board Of Trustees Of The Leland Stanford Junior University Procédés pour déterminer le risque de développer une résistance à l'insuline
US20240186000A1 (en) * 2019-10-16 2024-06-06 Icahn School Of Medicine At Mount Sinai Systems and methods for detecting a disease condition
CA3172199A1 (fr) * 2020-03-18 2021-09-23 Michael Nerenberg Systemes et procedes de detection d'un risque de maladie d'alzheimer a l'aide d'un dosage de profilage d'arnm sans circulation
CN112094355B (zh) * 2020-11-23 2021-05-11 南京佰抗生物科技有限公司 一种用于临床诊断的复合质控品及其制备方法
WO2023031447A1 (fr) * 2021-09-06 2023-03-09 F. Hoffmann-La Roche Ag Procédé de contrôle de qualité automatisé de données chromatographiques et/ou de spectre de masse
WO2023158504A1 (fr) * 2022-02-18 2023-08-24 Sera Prognostics, Inc. Panels de biomarqueurs et méthodes de prédiction de prééclampsie

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120190561A1 (en) * 2010-11-15 2012-07-26 Ludwig Wildt Means and methods for diagnosing endometriosis

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE429511T1 (de) * 2001-03-01 2009-05-15 Epigenomics Ag Verfahren zur entwicklung von gensätzen zu diagnostischen und therapeutischen zwecken auf grundlage des expressions- und methylierungsstatus der gene
AU2002251366A1 (en) * 2001-05-02 2002-11-11 Oxford Glycosciences (Uk) Ltd Proteins, genes and their use for diagnosis and treatment of breast cancer
US7344892B2 (en) * 2003-09-23 2008-03-18 Beth Israel Deaconess Medical Center, Inc. Screening for gestational disorders
WO2006029838A2 (fr) * 2004-09-14 2006-03-23 Geneprot Inc. Especes polypeptidiques secretees impliquees dans la maladie d'alzheimer
US20060223131A1 (en) * 2004-09-15 2006-10-05 Barry Schweitzer Protein arrays and methods of use thereof
JP2008513031A (ja) * 2004-09-20 2008-05-01 プロテオジェニックス， インコーポレイテッド 胎児異数性の診断
CA2593184A1 (fr) * 2005-01-06 2006-07-13 Eastern Virginia Medical School Isoforme d'apolipoproteine a-ii utilisee en tant que biomarqueur pour le cancer de la prostate
SI1929297T1 (sl) * 2005-09-29 2013-06-28 Caprion Proteomics Usa, Llc Bioloĺ ki oznaäśevalci pri multipli sklerozi in metode za njihovo uporabo
US7790463B2 (en) * 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
EP2924440A3 (fr) * 2006-06-07 2016-03-09 Health Diagnostic Laboratory, Inc. Marqueurs associés à des événements artériovasculaires et procédés d'utilisation de ceux-ci
WO2008054764A2 (fr) * 2006-10-31 2008-05-08 George Mason Intellectual Properties, Inc. Biomarqueurs pour cancer colorectal
WO2009097584A1 (fr) * 2008-01-30 2009-08-06 Proteogenix, Inc. Biomarqueurs de sérum maternel pour la détection de pré-éclampsie
CA2720863A1 (fr) * 2008-04-09 2009-10-15 The University Of British Columbia Procedes de diagnostic du rejet aigu d'une allogreffe cardiaque
EP2283155A4 (fr) * 2008-05-01 2011-05-11 Swedish Health Services Analyse de diagnostic d'accouchement prématuré
US20110256560A1 (en) * 2008-10-20 2011-10-20 University Health Network Methods and compositions for the detection of ovarian cancer
US20120157378A1 (en) * 2008-11-14 2012-06-21 Simin Liu Methods and Compositions for Predicting a Subject's Susceptibility To and Risk of Developing Type 2 Diabetes
WO2011032109A1 (fr) * 2009-09-11 2011-03-17 Sma Foundation Biomarqueurs de l'atrophie musculaire spinale
GB0922240D0 (en) * 2009-12-21 2010-02-03 Cambridge Entpr Ltd Biomarkers
US20130040844A1 (en) * 2010-01-28 2013-02-14 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers of aging for detection and treatment of disorders
TWI390204B (zh) * 2010-02-11 2013-03-21 Univ Chang Gung Biomarker of bladder cancer and its detection method
EP2601532B1 (fr) * 2010-08-06 2016-01-27 Mycartis N.V. Utilisation de perlecan en tant que biomarqueur d'un dysfonctionnement rénal
WO2013106886A1 (fr) * 2012-01-20 2013-07-25 Adelaide Research & Innovation Pty Ltd Biomarqueurs pour le cancer gastrique et leurs utilisations
US10054599B2 (en) * 2013-03-12 2018-08-21 Agency For Science, Technology And Research (A*Star) Pre-eclampsia biomarkers
US20140287947A1 (en) * 2013-03-15 2014-09-25 Sera Prognostics, Inc. Biomarkers and methods for predicting preeclampsia
BR112017027528A2 (pt) * 2015-06-19 2018-09-11 Sera Prognostics, Inc. composição, painel, método para determinar a probabilidade de parto prematuro em uma fêmea grávida e método de detecção de ibp4 e shbg em uma fêmea grávida?

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120190561A1 (en) * 2010-11-15 2012-07-26 Ludwig Wildt Means and methods for diagnosing endometriosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
C. E. POWE ET AL: "First Trimester Vitamin D, Vitamin D Binding Protein, and Subsequent Preeclampsia", HYPERTENSION., vol. 56, no. 4, 1 October 2010 (2010-10-01), US, pages 758 - 763, XP055302314, ISSN: 0194-911X, DOI: 10.1161/HYPERTENSIONAHA.110.158238 *

Also Published As

Publication number Publication date
AU2022221441A1 (en) 2022-09-22
US20190187145A1 (en) 2019-06-20
EP2972393A2 (fr) 2016-01-20
CA2907224C (fr) 2023-10-17
WO2014143977A3 (fr) 2014-12-18
US20140287947A1 (en) 2014-09-25
WO2014143977A2 (fr) 2014-09-18
EP3567371A1 (fr) 2019-11-13
CA3210007A1 (fr) 2014-09-18
US20190219588A1 (en) 2019-07-18
US20210156870A1 (en) 2021-05-27
AU2020201695B2 (en) 2022-05-26
US20140296108A1 (en) 2014-10-02
AU2014228009A1 (en) 2015-10-08
AU2020201695A1 (en) 2020-03-26
EP4344705A2 (fr) 2024-04-03
CA2907224A1 (fr) 2014-09-18

Similar Documents

Publication Publication Date Title
EP2972393A4 (fr) Biomarqueurs et procédés de prédiction de prééclampsie
EP2972308A4 (fr) Biomarqueurs et procédés de prédiction d'une naissance prématurée
EP2972089A4 (fr) Système et procédé pour déterminer et maintenir un emplacement et un état d'objet
EP2854053A4 (fr) Procédé et dispositif de prévision de défaut
GB201319779D0 (en) Genetic analysis method
EP3089152A4 (fr) Procédé de prédiction de durée de vie, programme de prédiction de durée de vie et dispositif de prédiction de durée de vie
SG11201506891YA (en) Pre-eclampsia biomarkers
EP2980207A4 (fr) Procédé de tri cellulaire
EP3063302A4 (fr) Procédés de détermination de la chimiosensibilité et de la chimiotoxicité
HK1212735A1 (zh) 用於評估免疫組庫的方法
HK1245892A1 (zh) 預測孕婦分娩時間的方法
EP2962105A4 (fr) Procédés et réactifs de détermination d'analytes isomériques
EP2954961A4 (fr) Procédé d'analyse de formage sous pression
GB201602019D0 (en) Method and load analysis for multi-off-center toools
GB201309426D0 (en) Biomarkers
EP3036712A4 (fr) Méthodes de prévision de pronostic
IL246403B (en) Methods and reagents for radioactive labeling
GB201316526D0 (en) Biomarkers
GB201308077D0 (en) Biomarkers
HK1217761A1 (zh) 用於診斷先兆子癇的方法和組合物
IL240033B (en) A method to assess the aging of a cell
PT2821771T (pt) Método de teste
GB201306339D0 (en) Biomarkers for prognosis
GB201316524D0 (en) Biomarkers
GB201312638D0 (en) Biomarkers

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20151013

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20160927

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/68 20060101AFI20160921BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180102

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20181207

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190418